Table 5 Predictors of factors associated with TB infection among HIV positive adults visiting ant-retroviral treatment centers at east and west Gojjam, Northwest, Ethiopia, 2017
Variables | Cases N = 139 | Controls N = 413 | COR(95%CI) | AOR (95%CI) |
|---|---|---|---|---|
Drinking alcohol | ||||
 Yes | 49(35.3) | 71(17.2) | 2.62(1.70,4.04) | 2.33(1.34,4.07) |
 No | 90(64.7) | 342(82.8) | 1 | 1 |
TB history in the family | ||||
 Yes | 33(23.7) | 41(9.9) | 2.83(1.70,4.69) | 3.0(1.57,5.74) |
 No | 106(76.3) | 372(90.1) | 1 | 1 |
WHO staging | ||||
 StageI/II | 38(27.3) | 273(66.1) | 0.19(0.12,0.30) | 0.34(0.20,0.56) |
 Stage III/IV | 101(72.7) | 140(33.9) | 1 | 1 |
CPT prophlaxysis | ||||
 Yes | 82(60) | 328(79.4) | 0.37(0.25,0.56) | 0.36(0.21,0.62) |
 No | 57(40) | 85(20.6) | 1 | 1 |
Functional status | ||||
 Bedridden | 71(51.1) | 36(8.7) | 5.5(3.13,9.67) 16.1(9.43,27.4) | 3.3(1.70,6.29) |
 Ambulatory | 33(23.7) | 92(22.3) | 1 | 8.2(4.34,15.64) |
 Working | 35(25.2) | 285(69) |  | 1 |
CD4 count | ||||
 ≤200/μl | 62(44.6) | 64(15.5) | 2.55(1.62,4.02) | 2.34(1.89,2.79) |
 201-499 μl | 62(44.6) | 163(39.5) | 12.01(6.39,22.6 | 2.63(1.01,6.84) |
 ≥500 μl | 15(10.8) | 186(45) | 1 | 1 |
BMI | ||||
 < 18.5 kg/m2 | 103(74) | 125(30.3) | 6.59(4.27,10.17 | 3.03(1.79,5.14) |
 ≥18.5 kg/m2 | 36(26) | 288(69.7) | 1 | 1 |